# Eliza F. Chakravarty

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eliza-f-chakravarty/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,272 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 42 |
| i10-index | 78 |
| Last Known Institution | Oklahoma Medical Research Foundation |
| OpenAlex ID | https://openalex.org/A5028844073 |
| Works | 446 |

## Researcher papers

- [Pregnancy outcomes after maternal exposure to rituximab](https://scholariq.org/papers/pregnancy-outcomes-after-maternal-exposure-to-rituximab/)
- [Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study](https://scholariq.org/papers/lack-of-placental-transfer-of-certolizumab-pegol-during-pregnancy-results-from/)
- [Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization data](https://scholariq.org/papers/prevalence-of-adult-systemic-lupus-erythematosus-in-california-and-pennsylvania/)
- [Reduced Disability and Mortality Among Aging Runners](https://scholariq.org/papers/reduced-disability-and-mortality-among-aging-runners/)
- [Compression of Morbidity 1980–2011: A Focused Review of Paradigms and Progress](https://scholariq.org/papers/compression-of-morbidity-1980-2011-a-focused-review-of-paradigms-and-progress/)
- [Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double‐blind, placebo‐controlled, dose‐escalating trial](https://scholariq.org/papers/reduced-b-lymphocyte-and-immunoglobulin-levels-after-atacicept-treatment-in/)
- [Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus](https://scholariq.org/papers/factors-that-predict-prematurity-and-preeclampsia-in-pregnancies-that-are/)
- [Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis](https://scholariq.org/papers/obstetric-hospitalizations-in-the-united-states-for-women-with-systemic-lupus/)
- [2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2022-american-college-of-rheumatology-guideline-for-vaccinations-in-patients/)
- [Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.](https://scholariq.org/papers/skin-cancer-rheumatoid-arthritis-and-tumor-necrosis-factor-inhibitors/)
- [Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death](https://scholariq.org/papers/prognostic-significance-of-repeat-biopsy-in-lupus-nephritis-histopathologic/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Pregnancy and Medication Impact](https://scholariq.org/topics/pregnancy-and-medication-impact/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)
- [Reproductive System and Pregnancy](https://scholariq.org/topics/reproductive-system-and-pregnancy/)

## Researcher university

- [Oklahoma Medical Research Foundation](https://scholariq.org/institutions/oklahoma-medical-research-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.